Remedy Q3: Full-year projection intact despite somewhat weak quarterly revenue - Redeye

Revenues came in lower than expected during the quarter. However, Remedy communicated in its outlook that the company still expects its revenue to remain at the previous year’s level, which means a big chunk of revenue is expected in Q4. This also means we will not make any meaningful adjustments to our full-year revenue estimate for 2022.

Länk till analysen i sin helhet: https://www.redeye.se/research/860490/remedy-q3-full-year-projection-intact-despite-somewhat-weak-quarterly-revenue?utm_source=finwire&utm_medium=RSS